brompheniramine maleate 4 MG / codeine phosphate 20 MG Oral Tablet [BroveX CB]
RxNorm concept 1356809, branded drug (sbd). Prescribable name: BroveX CBX 4 MG / 20 MG Oral Tablet.
- RxCUI
- 1356809
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1356809 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
BroveX CBX (brompheniramine maleate 4 MG / codeine phosphate 20 MG) Oral Tablet
Related concepts
- codeine phosphate 20 MG (SCDC, consists of)
- brompheniramine maleate 4 MG (SCDC, consists of)
- brompheniramine maleate 4 MG / codeine phosphate 20 MG [BroveX CB] (SBDC, consists of)
- Oral Tablet (DF, has dose form)
- BroveX CB (BN, has ingredient)
- brompheniramine maleate 4 MG / codeine phosphate 20 MG Oral Tablet (SCD, tradename of)
Linked data
NDCs
- 42819010601
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1356809 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1356809 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1356809. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.